Pioglitazone to Treat Fatty Liver in People With HIV Infection

NCT00441272 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

100

Enrollment

NIH

Sponsor class

Conditions

HIV Infections
Hepatic Steatosis
Insulin Resistance

Interventions

DRUG: Pioglitazone

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)